Shaping the future of healthcare
M42’s Integrated Health Solutions platform drives national programs and population health initiatives, addressing global health challenges through precision, prevention, and predictive care. Key initiatives include the Emirati Genome Program (EGP), which maps Emirati genetics for personalized and preventive healthcare, and Abu Dhabi BioBank, a regional hub accelerating drug discovery and biobanking excellence. Biogenix Labs advances precision medicine with Next-Generation Sequencing (NGS) technology, while Environmental Sciences analyzes non-human factors impacting public health. Supporting innovation, IROS drives high-quality clinical research, reinforcing M42’s commitment to transforming healthcare for a healthier, more sustainable future.
